AMETEK Announces Fourth Quarter 2025 Earnings Call and Webcasted Investor Conference Call Information
SkyBitz Introduces the ST705 Radar Monitor: A C1D1, Non-Invasive Solution for Accurate, Real-Time Tank Monitoring
AMETEK Appoints Robert J. Amodei Senior Vice President, Controller and Scott M. DelOrefice, Vice President, Group Controller
EMP METALS ADVANCES CONSTRUCTION OF PROJECT AURORA DEMONSTRATION PLANT BY COMPLETING INTERIOR FINISHING
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
